Smokers with co-occurring mental illness or substance use disorders are not designated a disparity group or priority population by most national public health and tobacco control groups.
These smokers fulfill the criteria commonly used to identify groups that merit special attention: targeted marketing by the tobacco industry, high smoking prevalence rates, heavy economic and health burdens from tobacco, limited access to treatment, and longer durations of smoking with less cessation. A national effort to increase surveillance, research, and treatment is needed.
Designating smokers with behavioral health comorbidity a priority group will bring much-needed attention and resources. The disparity in smoking rates among persons with behavioral health issues relative to the general population will worsen over time if their needs remain ELIMINATING DISPARITIES IN health and health care is a major priority in the United States. 1, 2 Groups with health disparities are referred to as vulnerable or priority populations and can be defined by factors such as race/ethnicity, socioeconomic status, geography, gender, age, disability status, or sexual orientation. 3 The sources of these disparities are complex, rooted in historic and social inequities. 4 Cigarette smoking, the leading cause of preventable death, is listed as one of 21 conditions with ongoing health disparities that must be addressed. 1 Indeed, as the American Legacy Foundation points out, tobacco is not an equal opportunity killer. 5 The criteria organizations such as the Centers for Disease Control and Prevention use to designate a tobacco disparity group are that they experience disproportionate tobacco consumption, disproportionate consequences or health burden from tobacco use, disproportionate economic burden from tobacco use, or limited access to tobacco-related health care. 1, 6, 7 These groups may also be targeted by the tobacco industry with special marketing. 6 Increased tobacco consumption may stem from differences in risk for tobacco use initiation or progression, differences in tobacco use prevalence and rates of nicotine dependence, and differences in smoking cessation rates.
Smokers with a co-occurring mental illness or substance use disorder (SUD) have historically been underserved. Table 1 ).
REVIEW OF EVIDENCE
This article reviews the literature that supports the need to recognize and identify smokers with behavioral health comorbidity as an important disparity group of tobacco users in the United States today. The validity of designating smokers with comorbid mental illness or SUDs as a priority population is shown by applying each of the criteria that qualify other groups for this attention to the population of smokers with behavioral health comorbidity.
Disproportionate Tobacco Consumption
According to Healthy People 2020, a disparity exists if a health outcome is greater in certain populations. 2 In the past 20 years, numerous studies have demonstrated higher rates of ever, daily, and heavy smoking among Americans with mental illness or SUDs than among individuals without these conditions.
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Studies have documented higher rates of smoking in nearly every type of behavioral health condition. 24 contribute to higher prevalence rates. This has been shown in clinical populations as well as in population data. 24, 25, 49, 50 There is evidence that not only are current symptoms and illness severity related to quitting smoking, but even a history of a disorder, such as major depression, is linked to lower short-and long-term abstinence. 28, 51 Specialty tobacco cessation services also have reported that behavioral health comorbidity is a predictor of reduced cessation. 33, 37, 52 Groups with greater risk for tobacco use progression are also considered priority populations. Studies have found that youths with behavioral health comorbidity are more likely to progress to nicotine dependence or daily smoking. 53---58 
Disproportionate Health Consequences
The consequences of tobacco use among persons with mental illness or SUDs are considerable: increased morbidity, mortality, and burden of tobacco-related illness relative to those without behavioral disorders. Evidence shows that tobacco contributes to more deaths in this group than does the primary behavioral health disorder. 61 Note. LGBT = lesbian, gay, bisexual, transgender; NCS = National Comorbidity Study; NHIS = National Health Interview Survey; NSDUH = National Survey on Drug Use and Health; NYTS = National Youth Tobacco Survey; PRAMS = Pregnancy Risk Assessment and Monitoring System; SES = socioeconomic status. a Measured by the K6 scale. 44 understanding price sensitivity is that smokers with behavioral health comorbidity are not a single group but reflect a large spectrum of illnesses, with varying socioeconomic status and degrees of disability. Smokers with serious mental illness, although perhaps the most financially burdened, represent a relatively small segment (< 10%) of the entire group with behavioral health comorbidity.
Targeted Marketing by the Tobacco Industry
The tobacco industry targets marketing to vulnerable or receptive populations such as young adults, socially disadvantaged groups, and various racial/ethnic groups. 79 Ample evidence shows that the tobacco industry segments consumer markets and targets advertising toward psychosocial needs satisfaction. Marketing addresses psychological needs such as stress relief, behavioral arousal, performance enhancement, and obesity reduction. 80, 81 Evidence from tobacco industry document review reveals targeting to psychologically vulnerable populations, including the mentally ill. Until recently, most psychiatric hospitals sold cigarettes in the hospital store, and they received frequent sales promotions and giveaways from major cigarette companies promoting value brands. 82 The tobacco industry also supported efforts to block smoking bans in these settings. 83 
Reduced Access to Resources
One factor that may be linked to the continued high prevalence of smoking among people with mental illness and SUDs is lack of access to cessation services, particularly in the behavioral health setting. Rates of tobacco documentation and treatment in these settings are very low, 9, 10 and psychiatrists are less likely than physicians in other specialties to be aware of state-funded tobacco services. 11 In psychiatry residency training programs, tobacco education is not a requirement, and only half of programs provide it. 84 A survey conducted by the Association of American Medical Colleges found that few psychiatrists reported being very well prepared by previous education to help patients stop smoking, and more than 30% felt that continuing education was unavailable.
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Because many individuals with behavioral health conditions are treated in the primary care setting, strategies are needed to help these smokers in a variety of health care settings. Models for collaborative care management are increasingly being used to deliver evidencebased practices for behavioral health problems in mental health settings. 85 Some models for medical health homes are locating behavioral health professionals in primary care physicians' offices to provide better access to services; this may provide opportunities for addressing tobacco addiction.
DISPARITY DESIGNATION
Smokers with behavioral health comorbidity clearly meet the definition of a tobacco use disparity group. In fact, they fulfill all the criteria commonly used to designate such groups. Individuals with behavioral health comorbidity are a considerable portion of the remaining smokers in the United States. Although the classification of behavioral health comorbidity is broad and inclusive, other disparate groups defined by race or gender are also broad and inclusive. Some groups that have been classified as tobacco use disparity groups have tobacco use prevalence rates that are lower than those of comorbid smokers (Table 2). 14, 17,38--- 44 The disparity in smoking rates between persons with behavioral health conditions and the general population may also worsen over time if their needs remain unaddressed.
Effects of Designation
Designation as a priority group is not merely an academic issue. It can lead to greater access to scientific funding and treatment resources, which in turn may lead to the development and evaluation of tailored and therefore more effective smoking cessation interventions. Furthermore, models for integrating smoking cessation services into behavioral health care and outreach models to link smokers with behavioral health comorbidity who are not receiving any health care to services can be developed and tested. Although this has not been measured, it is likely that minimal tobacco control dollars at the state or federal level are being directed toward this group. Several factors likely contribute to the absence of a significant national agenda on behavioral health and smoking comorbidity. National behavioral health organizations have been slow to organize on this issue, and behavioral health advocacy groups have not been advocating for greater access to resources. Research on tobacco use and behavioral health spans at least three separate agencies in the National Institutes of Health (the National Institute on Drug Abuse, National Institute of Mental Health, and National Cancer Institute), yet not one joint funding announcement or special request for applications for research on this comorbidity has appeared. Partnerships are needed between state tobacco control offices (often located in departments of health) and behavioral health services (often located in departments of human services) to develop effective strategies and share resources.
Finally, lack of attention given to smokers with behavioral health comorbidity may represent stigma, because no other group with such profound evidence of tobacco devastation has been neglected in a similar way. Prejudice and discrimination are believed to be important contributors to the production of health disparities, 4 and behavioral health disorders carry society's most negative stigma. Unconscious forms of bias exist even in the absence of overt expressions of prejudicial attitudes, and, although these stigma models originated from studies of race, they are increasingly being applied to populations with mental illness or obesity. 86 Stigma contributes to the belief that comorbid smokers cannot or will not give up tobacco because it is "all they have." Evidence for this is found in the scarcity of smoking cessation activity or discussion at prominent conferences and publications in behavioral health recovery. We have seen groups that champion recovery models for overcoming behavioral health disorders nonetheless subtly undermine smokers' sense that they can recover from tobacco dependence as well. Interestingly, similar claims are not made to justify use of other addicting and deadly substances in behavioral health care. A limitation of our review was that data sources for this population are incomplete. Many gaps exist in the current literature, and we have better estimates of tobacco use prevalence in other segments of the population. Making comorbid smokers a priority population, however, would greatly increase surveillance and improve existing data collection instruments to ensure that behavioral health comorbidity is being assessed in national data sets that track tobacco use. Reaching the national Healthy People 2020 goal 2 of eliminating health disparities related to tobacco use will necessitate improved collection and use of standardized and qualitative data to identify disparities in both health outcomes and efficacy of prevention programs among various population groups.
Need for a National Effort
Smokers with behavioral health comorbidity have received attention in peer-reviewed publications in relevant journals, but these represent the efforts of individual scientists and are not reflective of a unified or purposeful effort. Our review of key public health and tobacco control Web sites showed that this issue is still largely invisible. A critical aspect of designating a disparity group is recognizing that standard or population-based approaches that benefit many people may not work. California, which has the lowest smoking rates in the country, has found that statewide tobacco control approaches may not benefit some disparity groups, such as lesbian, gay, bisexual, and transgender persons and military personnel. 88 The group of people with behavioral health issues likely comprises many subgroups with important distinctions stemming from diagnosis, illness severity, and functional impairment that are best addressed by tailored tobacco control approaches. When working with vulnerable tobacco-using populations, it is critical to understand in detail the cultural context of smoking and quitting, which may be best ascertained through qualitative research. 89 Resources should be directed toward those with greatest need. The only group that approximates the smoking prevalence rates of comorbid smokers is low-income smokers, and presumably these groups overlap to some degree. Future tobacco control efforts should prioritize low-income and comorbid smokers. Funding decisions should reflect current need and not merely replicate activities of the past. In addition to enhanced surveillance, priority should be given to tobacco control funding that seeks to answer basic questions about access to treatment, effectiveness of evidencebased treatments, and barriers to cessation for smokers with behavioral health comorbidity. Studies are also needed to assess whether this group benefits from traditional tobacco control techniques, such as taxation and clean indoor air legislation. A national effort to address educational deficits and policies to promote tobacco treatment by behavioral health professionals is also needed.
Behavioral health is one of only three groups meeting all criteria for a tobacco use disparity group (Table 3) . Although racial/ethnic minorities and persons with low socioeconomic status also meet all criteria, they meet criteria with lower severity. Smoking prevalence is higher among persons with behavioral health conditions than among nearly all other groups that bear disparity burdens. We are, therefore, confident that smokers with behavioral health comorbidity are the disparity group most deserving of attention in the United States today. j 
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